Safety and Early Feasibility Study of the Harpoon Medical Device (EFS)

NACompletedINTERVENTIONAL
Enrollment

13

Participants

Timeline

Start Date

February 15, 2015

Primary Completion Date

March 21, 2016

Study Completion Date

July 16, 2021

Conditions
Mitral Valve RegurgitationMitral Valve ProlapseMitral Valve Insufficiency
Interventions
DEVICE

Harpoon Medical Device

It is expected that the Harpoon Medical transapical suturing device will be a valuable treatment alternative for patients suffering from mitral valve regurgitation because it can access the left ventricle with a small shaft or via a small valved introducer with a secure anchoring mechanism that can be deployed anywhere on the mitral valve leaflet.

Trial Locations (2)

31-202

John Paul II University Hospital, Krakow

04-628

Instytut of Kardiologii & Transplantology, Warsaw

Sponsors
All Listed Sponsors
lead

Edwards Lifesciences

INDUSTRY